fbpx
QQQ
+ 0.00
303.85
+ 0%
DIA
+ 0.00
299.16
+ 0%
SPY
+ 0.00
366.82
+ 0%
TLT
+ 0.00
156.25
+ 0%
GLD
+ 0.00
171.53
+ 0%

Flush With Money and Ballot Victories, Cannabis Lobbyists Call For Unified Effort

November 14, 2020 2:50 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Cannabis reform is riding a high off the heels of Election Day, with much of the credit going to the work of advocates and lobbyists.

The combined efforts at the federal and state levels are crucial to the cannabis movement, which has over two-thirds of the country's support.

Recent data from Marijuana Business Daily and Ballotpedia found that financial support is also pouring in. In 2020, pro-cannabis ballot measures outraised the opposition 36-to-1, a substantial increase from 2016's 4-to-1 outpacing.

Lobbyists and advocates are serving crucial roles in generating these funds and impacting the legislative process.

"Advocates and industry leaders who actively participate in face-to-face lobbying meetings, when it is safe to do that again, can have a tremendous impact on the reform process, as nothing demonstrates commitment like showing up on the Hill for meetings," said Brady Cobb, an attorney and CEO of Bluma Wellness (CSE:BWEL) and One Plant Florida, who began federal cannabis lobbying efforts in 2017. 

Related link: Why Being An Advocate Matters In The Cannabis Industry

Well-Represented, With Room For Collaboration
Industry lobbyists told Benzinga that federal reform has its fair share of representation.

Chris Lindsey, director of government relations for the Marijuana Policy Project (MPP), feels there is adequate coverage, noting over a dozen reform groups in Washington D.C.

"If anything, there is the sense there are too many voices vying for attention in D.C., which includes those seeking criminal justice reform and those with more commercial interests," Lindsey said. "Fortunately, while there are many voices, I think there is a great deal of agreement among them and generally a willingness to cooperate."

Cobb has a similar view.

There's "a very cohesive group in the House" led by Laura Thrift from Rep. Earl Blumenauer's office, Cobb said, adding that no single group is leading the charge in the Senate.

The hope among some lobbysists is that these groups form a coalition to unify goals and lobby at the capital in-person.

"I cannot underscore how important it is for industry stakeholders to personally appear," Cobb said, highlighting the Cannabis Trade Federation as one to watch.

Dr. Chanda Macias, CEO of medical dispensary National Holistic, highlighted the Minority Cannabis Business Association and the National Cannabis Roundtable. Macias, who heads up the organization Women Grow, also credited drug policy groups like Americans for Safe Access, NORML and Drug Policy Alliance for advancing reform efforts.

"We are seeing more associations emerging on the state level, but as we continue to expand across the country it would not surprise me to see more nationally," Macias said.

Related link: Jack Herer: A Lifelong Cannabis Advocate

Where Does The Money Come From?

Tracking the funds for lobbying efforts varies at the state level, as each state has its own set of issues and localized players. But at the federal level, it is clear that pro-cannabis funding has made substantial leaps in recent years.

Data from OpenSecrets and the Center for Responsive Politics show that the $5.7 million spent in 2019 was more than double that of the previous year's $2.78 million.

The capital saw 92 lobbyists pushing for reform in 2019, backed by 17 clients. The Cannabis Trade Federation led the charge, spending $1.3 million toward efforts. As of October, 2020 has seen $3.15 million in contributions.

Morgan Fox, director of media relations for the National Cannabis Industry Association, said that a lot of lobbying efforts "were curtailed a bit" due to the pandemic. However, funds are still rolling in.

Curaleaf Holdings Inc. (OTCQX:CURLF), for example, has given $890,000. Other brands have also contributed, including Parallel Brands, Canopy Growth Corp (NYSE:CGC) and Canndescent.

Additional data show that individuals and PACs donated $471,000 during the 2018 election cycle. Of the donations, 64% went to Republican candidates, up from 42% during the 2016 election cycle.

Drug policy advocacy groups face more of a challenge, according to MPP's Lindsey. MPP receives its funding from individual donors and cannabis brands.

The director said that reform efforts are victims of their success, where funding can dry up as the public assumes the fight is mostly over. A state ballot initiative costs millions of dollars and is a standard part of the process.

Contributions largely support ballot efforts, as well as lobbying and staff payroll.

Lindsey said the work continues after a law passes.

"If we 'legalize' but still put more or less the same people in jail for cannabis-related activity, we haven't really achieved our goal of ending prohibition," Lindsey said.

Brady Cobb, CEO of Bluma Wellness; Image Courtesy of Bluma Wellness


Related Articles

Home Cannabis Cultivation Continues, Despite Opposition From Many Marijuana Companies

Home cultivation has emerged as a clear sticking point in cannabis reform across many states. While it faces pushback, including from several cannabis brands, home grow is making incremental progress in medical and adult use markets, and ushering in a variety of parameters to meet state needs.  read more

United Nations Commission Reschedules Cannabis In Historic Vote Following WHO Suggestion

The United Nations Commission on Narcotic Drugs has made a final decision to remove cannabis from Schedule IV of the 1961 Single Convention on Narcotic Drugs. Cannabis advocates have waited almost two years for the vote. read more

Why A Biden-Appointed, Pro-Cannabis Attorney General Is Important For Weed Reform

As President-Elect Joe Biden fills out his cabinet and other administration roles, potential candidates for Attorney General have been mentioned. read more

C21 Expands Cannabis Cultivation Facility In Nevada, Expects To Triple Flower Output

Cannabis company C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) has plans to development its cultivation and production facility in Nevada. The Vancouver-based company aims to add 40,000 square-feet, including 11 new flowering rooms and two vegetative rooms. read more

Cannabis Movers And Shakers: Khiron, Allied, CGOC, Valens, iAnthus, Sanity Group, ALTWELL CBD, PharmaCielo

Here is a summary of the latest company shakeups within the cannabis industry. read more